The University of Waterloo is a public research university with a main campus in Waterloo, Ontario, Canada. The main campus is on 404 hectares of land adjacent to "Uptown" Waterloo and Waterloo Park. The university also operates three satellite campuses and four affiliated university colleges.

During the past decade, University of Waterloo conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 8 clinical trials were completed, i.e. on average, 32% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 7 clinical trials were completed. i.e. 63.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Waterloo" #1 sponsor was "University of Waterloo" with 18 trials, followed by "Coopervision, Inc." with 6 trials sponsored, "CIBA VISION" with 2 trials sponsored, "Bausch & Lomb Incorporated" with 1 trials sponsored and "Johnson & Johnson Vision Care, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Waterloo" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 3 trials as a collaborator, "Grand River Regional Cancer Centre" with 2 trials as a collaborator, "The Hong Kong Polytechnic University" with 2 trials as a collaborator, "University Health Network, Toronto" with 2 trials as a collaborator and "University of Waterloo" with 2 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "University of Waterloo" are "Myopia" (4 trials), "Osteoporosis" (3 trials), "Cancer" (2 trials), "Dementia" (2 trials) and "Macular Degeneration" (2 trials). Many other conditions were trialed in "University of Waterloo" in a lesser frequency.

Most popular intervention types in "University of Waterloo" are "Device" (13 trials), "Other" (8 trials), "Behavioral" (6 trials), "Dietary Supplement" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "etafilcon A" (2 trials), "somofilcon A" (2 trials), "Active anodal tDCS" (1 trials), "CHO" (1 trials) and "Centre-based exercise" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Waterloo" are 26 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University of Waterloo". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in University of Waterloo, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Waterloo, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 28 trials that are defined as “Not Applicable".

University of Waterloo has several departments that took part in Clinical trials: "University of Waterloo School of Optometry" - 9 trials